Neuroendocrine Carcinoma Clinical Trials in Paris
6 recruitingParis, France
Showing 1–6 of 6 trials
Recruiting
Phase 2
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Neuroendocrine NeoplasmsSmall Cell Lung CarcinomaExtra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim204 enrolled59 locationsNCT05882058
Recruiting
Phase 3
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Neuroendocrine Carcinoma
Intergroupe Francophone de Cancerologie Thoracique129 enrolled40 locationsNCT06937905
Recruiting
Phase 2
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Soft Tissue SarcomaPancreatic AdenocarcinomaAdrenocortical Carcinoma+2 more
UNICANCER120 enrolled22 locationsNCT06333314
Recruiting
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
CholangiocarcinomaHepatoblastomaFibrolamellar Carcinoma+7 more
Federation Francophone de Cancerologie Digestive150 enrolled40 locationsNCT06541652
Recruiting
Phase 2
Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas
Digestive CancerNeuroendocrine Carcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group78 enrolled14 locationsNCT04268121
Recruiting
Phase 2
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Large Cell Neuroendocrine Carcinoma of the Lung
Centre Leon Berard80 enrolled31 locationsNCT06393816